9-34723300-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001141917.2(SPATA31F1):āc.3940T>Cā(p.Tyr1314His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000251 in 1,551,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001141917.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA31F1 | NM_001141917.2 | c.3940T>C | p.Tyr1314His | missense_variant | 4/4 | ENST00000378788.4 | NP_001135389.1 | |
PHF24 | XM_047423102.1 | c.133+20262A>G | intron_variant | XP_047279058.1 | ||||
PHF24 | XM_047423103.1 | c.70+20262A>G | intron_variant | XP_047279059.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA31F1 | ENST00000378788.4 | c.3940T>C | p.Tyr1314His | missense_variant | 4/4 | 2 | NM_001141917.2 | ENSP00000417711 | P1 | |
ENST00000664167.1 | n.86+20262A>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000128 AC: 2AN: 155970Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82688
GnomAD4 exome AF: 0.0000229 AC: 32AN: 1399352Hom.: 0 Cov.: 65 AF XY: 0.0000246 AC XY: 17AN XY: 690182
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74314
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at